Treatment Intensification by Stepwise Addition of Prandial Insulin Aspart to Once-Daily Basal Insulin Detemir in Subjects with Type 2 Diabetes: The STEPwise™ Trial

被引：0
|
作者：
Meneghini, Luigi F.
Hermansen, Kjeld
Mersebach, Henriette
Svendsen, Anne Louise
Kumar, Sudhesh
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A199 / A199
页数：1
相关论文
共 50 条
  • [1] The STEPwise™ randomised, controlled, 48-week trial: intensifying treatment with stepwise addition of prandial insulin aspart, based on largest prandial glucose increment or largest meal, to once daily basal insulin detemir in subjects with type 2 diabetes
    Hermansen, K.
    Kumar, S.
    Mersebach, H.
    Svendsen, A. L.
    Meneghini, L.
    [J]. DIABETOLOGIA, 2010, 53
  • [2] Detemir as a once-daily basal insulin in type 2 diabetes
    Nelson, Scott E.
    [J]. CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2011, 3 : 27 - 37
  • [3] Stepwise intensification of prandial insulin versus basal-bolus insulin therapy in patients with type 2 diabetes mellitus
    Raccah, D.
    Haak, T.
    Huet, D.
    Monnier, L.
    Ramon, J. S.
    Robertson, D.
    Labard, P.
    Penfornis, A.
    [J]. DIABETOLOGIA, 2010, 53
  • [4] Similar glucose control with basal bolus regimen of insulin detemir plus insulin aspart and thrice-daily biphasic insulin aspart 30 in insulin-naive patients with type 2 diabetes: Results of a 50-week randomized clinical trial of stepwise insulin intensification
    Malek, R.
    Ajili, F.
    Assaad-Khalil, S. H.
    Shinde, A.
    Chen, J. W.
    Van den Berg, E.
    [J]. DIABETES & METABOLISM, 2015, 41 (03) : 223 - 230
  • [5] Insulin degludec/insulin aspart once daily in Type 2 diabetes: a comparison of simple or stepwise titration algorithms (BOOST®: SIMPLE USE)
    Park, S. W.
    Bebakar, W. M. W.
    Hernandez, P. G.
    Macura, S.
    Herslov, M. L.
    de la Rosa, R.
    [J]. DIABETIC MEDICINE, 2017, 34 (02) : 174 - 179
  • [6] Similar gulcose control with basal-bolus regimen of insulin detemir plus insulin aspart and thrice-daily biphasic insulin aspart 30 in insulin-naive patients wiwth type 2 diabetes: Results of a 50-week randomized clinical trial of stepwise insulin intensification
    Baminger, H.
    [J]. AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2015, 8 (03): : 87 - 88
  • [7] Cost Benefits of Stepwise Addition of Prandial Insulin Aspart Compared to Full Basal-Bolus Therapy
    Saunders, Rhodri
    Lian, Jean
    Valentine, William
    Karolicki, Boris
    [J]. DIABETES, 2014, 63 : A306 - A307
  • [8] Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes requiring insulin intensification: a randomized phase IV trial
    Tinahones, F. J.
    Gross, J. L.
    Onaca, A.
    Cleall, S.
    Rodriguez, A.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (10): : 963 - 970
  • [9] Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes
    Jang, Han Na
    Yang, Ye Seul
    Lee, Seong Ok
    Oh, Tae Jung
    Koo, Bo Kyung
    Jung, Hye Seung
    [J]. ENDOCRINOLOGY AND METABOLISM, 2019, 34 (04) : 382 - 389
  • [10] Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial
    Cho, Kyu Yong
    Nakamura, Akinobu
    Oba-Yamamoto, Chiho
    Tsuchida, Kazuhisa
    Yanagiya, Shingo
    Manda, Naoki
    Kurihara, Yoshio
    Aoki, Shin
    Atsumi, Tatsuya
    Miyoshi, Hideaki
    [J]. DIABETES & METABOLISM JOURNAL, 2020, 44 (04) : 532 - +
12345